Medicure (OTCMKTS:MCUJF) Stock Price Up 26.8% – Still a Buy?

Shares of Medicure Inc. (OTCMKTS:MCUJF) shot up 26.8% on Friday . The stock traded as high as $0.8554 and last traded at $0.8554. 10,020 shares were traded during mid-day trading, an increase of 500,900% from the average daily volume of 2 shares. The stock had previously closed at $0.6746.

Medicure Stock Performance

The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.03. The firm has a market cap of $8.93 million, a P/E ratio of -1.82 and a beta of 1.02. The business has a fifty day simple moving average of $0.75 and a 200-day simple moving average of $0.81.

Medicure (OTCMKTS:MCUJF) last announced its earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01. The firm had revenue of $5.79 million for the quarter, compared to analysts’ expectations of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.